Skip to content
10-K/A

Annual Report

CTT PHARMACEUTICAL HOLDINGS, INC. CTTH

0001553350-15-001055

← back to feed
Filed
Oct 8, 2015 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2014 · Sep 30, 2015 21.35M sh
Operating Cash Flow FY 2014 · Dec 31, 2014 −$72.25K
Operating Cash Flow restated FY 2014 · Dec 31, 2013 −$209
Cash And Equivalents FY 2014 · Dec 31, 2014 $81.18K
Stockholders Equity restated FY 2014 · Dec 31, 2014 $1.49M
Stockholders Equity restated FY 2014 · Dec 31, 2013 −$29.32K
Stockholders Equity restated FY 2014 · Dec 31, 2012 −$20K
Total Liabilities restated FY 2014 · Dec 31, 2014 $169.49K
Total Liabilities restated FY 2014 · Dec 31, 2013 $29.32K
Current Assets FY 2014 · Dec 31, 2014 $1.05M
Total Assets FY 2014 · Dec 31, 2014 $1.66M
Sga Expense FY 2014 · Dec 31, 2014 $17.64K
Sga Expense restated FY 2014 · Dec 31, 2013 $3.84K
Net Income restated FY 2014 · Dec 31, 2014 −$672.16K
Net Income restated FY 2014 · Dec 31, 2013 −$18.91K
Operating Income FY 2014 · Dec 31, 2014 −$672.16K
Operating Income restated FY 2014 · Dec 31, 2013 −$18.91K